Abstract
Abstract
Background
To ascertain interactions of caffeine ingestion, food, medications, and environmental exposures during preterm human gestation, under informed consent, we studied a cohort of Mexican women with further preterm offspring born at ≤ 34 completed weeks. At birth, blood samples were taken from mothers and umbilical cords to determine caffeine and metabolites concentrations and CYP1A2 (rs762551) and CYP2E1 (rs2031920, rs3813867) polymorphisms involved in caffeine metabolism.
Results
In 90 pregnant women who gave birth to 98 preterm neonates, self-informed caffeine ingestion rate was 97%, laboratory confirmed rate was 93 %. Theobromine was the predominant metabolite found. Consumption of acetaminophen correlated significantly with changes in caffeine metabolism (acetaminophen R2 = 0.637, p = 0.01) due to activation of CYP2E1 alternate pathways. The main caffeine source was cola soft drinks.
Conclusion
Environmental exposures, especially acetaminophen ingestion during human preterm pregnancy, can modulate CYP2E1 metabolic activity.
Funder
Instituto Tecnológico y de Estudios Superiores de Monterrey
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Fredholm BB, Bättig K, Holmén J et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83–133
2. Ådén U (2011) Methylxanthines During Pregnancy and Early Postnatal Life. In: Small Animal Toxicology. pp 373–389
3. Moura-Nunes, N. and Farah A (2012) Caffeine Consumption and Health. In: Russo PF RF (ed) Caffeine Consumption and Health. New York: Nova Science Publishers, Inc, New York
4. Grosso LM, Bracken MB (2005) Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy. Ann Epidemiol 15:460–466 https://doi.org/10.1016/j.annepidem.2004.12.011
5. Tsutsumi K, Kotegawa T, Matsuki S et al (2001) The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Clin Pharmacol Ther 70:121–125 https://doi.org/10.1067/mcp.2001.116495